These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism. Robertson L; Yeoh SE; Ramli A Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657 [TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol. Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889 [TBL] [Abstract][Full Text] [Related]
8. Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis. Schulman S; Zondag M; Linkins L; Pasca S; Cheung YW; de Sancho M; Gallus A; Lecumberri R; Molnar S; Ageno W; Le Gal G; Falanga A; Hulegårdh E; Ranta S; Kamphuisen P; Debourdeau P; Rigamonti V; Ortel TL; Lee A J Thromb Haemost; 2015 Jun; 13(6):1010-8. PubMed ID: 25851122 [TBL] [Abstract][Full Text] [Related]
9. Pentasaccharides for the prevention of venous thromboembolism. Dong K; Song Y; Li X; Ding J; Gao Z; Lu D; Zhu Y Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005134. PubMed ID: 27797404 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation bridging around device surgery: compliance with guidelines. Perrin MJ; Vezi BZ; Ha AC; Keren A; Nery PB; Birnie DH Pacing Clin Electrophysiol; 2012 Dec; 35(12):1480-6. PubMed ID: 22978770 [TBL] [Abstract][Full Text] [Related]
11. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes. Shaw JR; Douketis J; Le Gal G; Carrier M J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838 [TBL] [Abstract][Full Text] [Related]
12. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL; N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867 [TBL] [Abstract][Full Text] [Related]
13. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism. Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410 [TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD; Johnson JA; Turpie AG Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166 [TBL] [Abstract][Full Text] [Related]
16. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures. Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism. Coleman CI; Bunz TJ; Turpie AGG Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322 [TBL] [Abstract][Full Text] [Related]
18. Heparin Bridging Therapy for Patients on Chronic Oral Anticoagulants in Periprocedural Settings. Nikolakopoulos I; Spyropoulos AC Semin Thromb Hemost; 2020 Feb; 46(1):26-31. PubMed ID: 31830765 [TBL] [Abstract][Full Text] [Related]
19. Treatment of DVT: how long is enough and how do you predict recurrence. Agnelli G; Becattini C J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973 [TBL] [Abstract][Full Text] [Related]
20. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events. Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]